In a report released on November 15, David Rescott from Robert W. Baird maintained a Buy rating on Boston Scientific (BSX – Research Report), ...
Mizuho Securities analyst Anthony Petrone has maintained their bullish stance on BSX stock, giving a Buy rating yesterday.Don't Miss our Black ...
Abbott’s Amulet IDE trial put its left atrial appendage closure device up against the Watchman 2.5, which was approved by the ...
Abbott Park, Illinois Wednesday, November 20, 2024, 13:00 Hrs [IST] ...
Boston Scientific Corporation BSX recently announced favorable three-year primary endpoint data from the OPTION global ...
Baystate Medical Center now offers this minimally invasive surgery where a left atrial appendage closure device is implanted into your heart. The WATCHMAN device closes off your LAA to keep blood ...
Abbott (NYSE:ABT) announced new data supporting its Amplatzer Amulet left atrial appendage (LAA) occluder system.
IVC filters, implants that prevent blood clots, aren't meant to be permanent — but doctors often forge to retrieve them.
Three years after the U.S. FDA approval of Abbott Laboratories’ Amplatzer Amulet, results of its investigational device exemption trial failed to notably differentiate Abbott’s left atrial appendage ...
Cases of several dangerous bacterial infections and viruses have been growing around the U.S. CBS News medical contributor Dr ...
In 2010, Azadeh Dastmalchi's journey toward transforming healthcare began with a personal challenge. Her father's aversion to ...
Eight Sleep, the world’s first sleep fitness company, is proud to announce its expansion to the United Arab Emirates (UAE), ...